1999•Journal of NeurochemistryRequires access

Identification and Role of Serotonin 5‐HT1A and 5‐HT1B Receptors in Primary Cultures of Rat Embryonic Rostral Raphe Nucleus Neurons

Francis Hery, P. Boulenguez, A. Sémont, Micheline Héry, Giancarlo Pesce, Denis Becquet, Maxime Faudon, Paule Deprez, Marie Pierre Fache

Open publisher page 20 citations

Abstract

Abstract: Autoregulatory mechanisms affecting serotonin [5‐hydroxytryptamine (5‐HT)] release and synthesis during the early period of development were investigated in dissociated cell cultures raised from embryonic rostral rat rhombencephalon. The presence of 5‐HT1A and 5‐HT1B receptors in serotoninergic neurons was assessed using binding assays. The involvement of 5‐HT1A and 5‐HT1B receptors in the control of the synthesis and release of [3H]5‐HT was studied using biochemical approaches with several serotoninergic receptor ligands. A mean decrease of 30% in [3H]5‐HT synthesis and release was observed in the presence of 5‐HT (10−8M), the 5‐HT1A agonist 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OH‐DPAT), the 5HT1B/1A agonist 5‐methoxy‐3‐(1,2,5,6‐tetrahydro‐4‐pyridinyl)‐1H‐indole (RU 24969), the 5‐HT1B agonist 3‐(1,2,5,6‐tetrahydropyrid‐4‐yl)pyrrolo[3,2‐b]pyrid‐5‐one (CP‐93, 129), and the 5‐HT1D/1B agonist sumatriptan. Inhibition of 5‐HT synthesis and release induced by 8‐OH‐DPAT was blocked by chiral N‐tert‐butyl‐3‐[1‐[1‐(2‐methoxy)phenyl]piperazinyl]‐1‐phenylpropionamide dihydrochloride quaternary‐hydrate (WAY 100135) (10−7M) or methyl 4‐[4‐[4‐(1,1,3‐trioxo‐2H‐1,2‐benzoisothiazol‐2‐yl)butyl]‐1‐piperazinyl]‐1H‐indole‐2‐carboxylate (SDZ 216–525) (10−7M), and that of CP‐93, 129 was blocked by methiothepin (10−7M). Paradoxically, extracellular levels of [3H]5‐HT increased in the presence of 8‐OH‐DPAT and RU 24969 at 10−6M. 5‐HT uptake experiments showed that these two agonists interacted with the 5‐HT transporter. 5‐HT1 binding sites (620 fmol/mg of protein) and 5‐HT1A (482 fmol/mg of protein) and 5‐HT1B (127 fmol/mg of protein) receptors were detected in 12‐day in vitro cell cultures. Experiments carried out with tetrodotoxin suggested that 5‐HT1A receptors are located on nerve cell bodies, whereas 5‐HT1B receptors are located on the nerve terminals. We concluded that autoregulatory mechanisms involving 5‐HT1A and 5‐HT1B autoreceptors are functionally mature in cells from rostral raphe nuclei during the early period of development.

About this research paper

What this paper is about

Abstract: Autoregulatory mechanisms affecting serotonin [5‐hydroxytryptamine (5‐HT)] release and synthesis during the early period of development were investigated in dissociated cell cultures raised from embryonic rostral rat rhombencephalon. The presence of 5‐HT1A and 5‐HT1B receptors in serotoninergic neurons was assessed using binding assays. The involvement of 5‐HT1A and 5‐HT1B receptors in the control of the synthesis and release of [3H]5‐HT was studied using biochemical approaches with several serotoninergic receptor ligands. A mean decrease of 30% in [3H]5‐HT synthesis and release was observed in the presence of 5‐HT (10−8M), the 5‐HT1A agonist 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OH‐DPAT), the 5HT1B/1A agonist 5‐methoxy‐3‐(1,2,5,6‐tetrahydro‐4‐pyridinyl)‐1H‐indole (RU 24969), the 5‐HT1B agonist 3‐(1,2,5,6‐tetrahydropyrid‐4‐yl)pyrrolo[3,2‐b]pyrid‐5‐one (CP‐93, 129), and the 5‐HT1D/1B agonist sumatriptan. Inhibition of 5‐HT synthesis and release induced by 8‐OH‐DPAT was blocked by chiral N‐tert‐butyl‐3‐[1‐[1‐(2‐methoxy)phenyl]piperazinyl]‐1‐phenylpropionamide dihydrochloride quaternary‐hydrate (WAY 100135) (10−7M) or methyl 4‐[4‐[4‐(1,1,3‐trioxo‐2H‐1,2‐benzoisothiazol‐2‐yl)butyl]‐1‐piperazinyl]‐1H‐indole‐2‐carboxylate (SDZ 216–525) (10−7M), and that of CP‐93, 129 was blocked by methiothepin (10−7M). Paradoxically, extracellular levels of [3H]5‐HT increased in the presence of 8‐OH‐DPAT and RU 24969 at 10−6M. 5‐HT uptake experiments showed that these two agonists interacted with the 5‐HT transporter. 5‐HT1 binding sites (620 fmol/mg of protein) and 5‐HT1A (482 fmol/mg of protein) and 5‐HT1B (127 fmol/mg of protein) receptors were detected in 12‐day in vitro cell cultures. Experiments carried out with tetrodotoxin suggested that 5‐HT1A receptors are located on nerve cell bodies, whereas 5‐HT1B receptors are located on the nerve terminals. We concluded that autoregulatory mechanisms involving 5‐HT1A and 5‐HT1B autoreceptors are functionally mature in cells from rostral raphe nuclei during the early period of development.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract: Autoregulatory mechanisms affecting serotonin [5‐hydroxytryptamine (5‐HT)] release and synthesis during the early period of development were investigated in dissociated cell cultures raised from embryonic rostral rat rhombencephalon. The presence of 5‐HT1A and 5‐HT1B receptors in serotoninergic neurons was assessed using binding assays. The involvement of 5‐HT1A and 5‐HT1B receptors in the control of the synthesis and release of [3H]5‐HT was studied using biochemical approaches with several serotoninergic receptor ligands. A mean decrease of 30% in [3H]5‐HT synthesis and release was observed in the presence of 5‐HT (10−8M), the 5‐HT1A agonist 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OH‐DPAT), the 5HT1B/1A agonist 5‐methoxy‐3‐(1,2,5,6‐tetrahydro‐4‐pyridinyl)‐1H‐indole (RU 24969), the 5‐HT1B agonist 3‐(1,2,5,6‐tetrahydropyrid‐4‐yl)pyrrolo[3,2‐b]pyrid‐5‐one (CP‐93, 129), and the 5‐HT1D/1B agonist sumatriptan. Inhibition of 5‐HT synthesis and release induced by 8‐OH‐DPAT was blocked by chiral N‐tert‐butyl‐3‐[1‐[1‐(2‐methoxy)phenyl]piperazinyl]‐1‐phenylpropionamide dihydrochloride quaternary‐hydrate (WAY 100135) (10−7M) or methyl 4‐[4‐[4‐(1,1,3‐trioxo‐2H‐1,2‐benzoisothiazol‐2‐yl)butyl]‐1‐piperazinyl]‐1H‐indole‐2‐carboxylate (SDZ 216–525) (10−7M), and that of CP‐93, 129 was blocked by methiothepin (10−7M). Paradoxically, extracellular levels of [3H]5‐HT increased in the presence of 8‐OH‐DPAT and RU 24969 at 10−6M. 5‐HT uptake experiments showed that these two agonists interacted with the 5‐HT transporter. 5‐HT1 binding sites (620 fmol/mg of protein) and 5‐HT1A (482 fmol/mg of protein) and 5‐HT1B (127 fmol/mg of protein) receptors were detected in 12‐day in vitro cell cultures. Experiments carried out with tetrodotoxin suggested that 5‐HT1A receptors are located on nerve cell bodies, whereas 5‐HT1B receptors are located on the nerve terminals. We concluded that autoregulatory mechanisms involving 5‐HT1A and 5‐HT1B autoreceptors are functionally mature in cells from rostral raphe nuclei during the early period of development.

Key concepts: Serotonin, Serotonin Agonist, Agonist, 5-HT receptor, Serotonergic, 5-HT1 receptor, Receptor, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Identification and Role of Serotonin 5‐HT1A and 5‐HT1B Receptors in Primary Cultures of Rat Embryonic Rostral Raphe Nucleus Neurons — Research Paper | ScholarLens